Abstract
Momordica charantia has been found to exhibit anticancer activity, in addition to its well-known therapeutic functions. We have demonstrated that the leaf extract of Momordica charantia (MCME) induces apoptosis in several human cancer cells through caspase- and mitochondria-dependent pathways. In this study, a different susceptibility to MCME was found in human lung adenocarcinoma CL1 cells with different metastatic ability, leading to the significant difference of cell viability and invasiveness between MCME-treated CL1-0 and CL1-5 cells. MCME was found to upregulate the expression of Wnt-2 and affect the migratory and invasive ability of CL1 cells through suppressed MMP-2 and MMP-9 enzymatic activities. We proposed that MCME mediates inhibition against migration of CL1 cells by reducing the expression and activation of Src and FAK to decrease the expression of downstream Akt, β-catenin, and MMPs. © 2012 Hsue-Yin Hsu et al.
Cite
CITATION STYLE
Hsu, H. Y., Lin, J. H., Li, C. J., Tsang, S. F., Tsai, C. H., Chyuan, J. H., … Chuang, S. E. (2012). Antimigratory effects of the methanol extract from momordica charantia on human lung adenocarcinoma CL1 cells. Evidence-Based Complementary and Alternative Medicine, 2012. https://doi.org/10.1155/2012/819632
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.